Skip to main content
Clinical Trials/NCT01147757
NCT01147757UnknownNot Applicable

Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Yonsei University1 site in 1 country60 target enrollmentStarted: June 2010Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1
Primary Endpoint
fentanyl consumption for IV-PCA

Study Overview

Brief Summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
1 Year to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy

Exclusion Criteria

  • cardiovascular, renal, liver disease or growth retardation

Arms & Interventions

remifentanil 0.6 mcg/kg/min

Experimental

Group 0.6 (n = 15): remifentanil 0.6 mcg/kg/min

Intervention: remifentanil (Drug)

saline

Placebo Comparator

Group S (n = 15): saline

Intervention: remifentanil (Drug)

remifentanil 0.3 mcg/kg/min

Experimental

Group 0.3 (n = 15): remifentanil 0.3 mcg/kg/min

Intervention: remifentanil (Drug)

remifentanil 0.9 mcg/kg/min

Experimental

Group 0.9 (n = 15): remifentanil 0.9 mcg/kg/min

Intervention: remifentanil (Drug)

Outcomes

Primary Outcomes

fentanyl consumption for IV-PCA

Time Frame: 24 h and 48 h after surgery

Postoperative pain score

Time Frame: during 48 h after surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeong-Yeon Hong

associate professor

Yonsei University

Study Sites (1)

Loading locations...

Similar Trials

Effect of Intraoperative Remifentanil... | Clinical Trial